Our Story

The Lipoprotein(a) Association is dedicated to reducing heart attacks and strokes by driving research and awareness of lipoprotein(a) [Lp(a)]. Lp(a) is an important independent genetic risk factor for cardiovascular disease (CVD) and calcific aortic valve stenosis (AS).  We remove barriers and accelerate change for the 63 million Americans living with high Lp(a) by bringing together data-driven insights, medical expertise and the patient-perspective.

We empower patients

We believe that knowledge enables individuals to make informed choices to improve their care. And since Lp(a) is inherited, we know the difference that connecting families with resources can make.

We catalyze research

We harness the power of data – from our own research and registries to the publication of others – to drive improvements in the identification and care of Lp(a).

Our crusade is personal

We know that life can be cut too short by heart attacks and strokes. We believe in the difference that prevention makes.

Our Founder's Story

Katherine Wilemon is the founder of the Lipoprotein(a) Association and the Familial Hypercholesterolemia Foundation. Her own heart attack at 39 underscored the importance of not only understanding but acting upon genetic risk factors for heart disease, including high Lp(a) and FH. Faced with a lack of awareness and apathy within the medical community and general public, Katherine set out to make a difference for herself, her family, and the tens of millions of families worldwide.
Katherine Wileomon